Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RE-NOVATE II: Dabigatran vs Enoxaparin for VTE Prevention in Hip Arthroplasty
NCT00657150Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 2008
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 19
01
Overview
A Phase 3 trial of dabigatran in venous thromboembolism (VTE), sponsored by Boehringer Ingelheim. Started Mar 2008; status: completed.
02
Drugs
dabigatran
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00657150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00657150.